[ACRX] QoQ Quarter Result on 31-Dec-2020 [#Q4]

Stock
[ACRX] AcelRx Pharmaceuticals, Inc.
Announcement Date
15-Mar-2021
Financial Year
2020
Quarter
31-Dec-2020 [#Q4]
Profit Trend
QoQ- 0.13%
YoY- 38.17%
Quarter Report
ACRX's Result
ACRX's Financial Summary
View:
Show?
Quarter Result
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
Revenue 1,862 443 511 738 1,368 2,924 386 185.21%
PBT -8,375 -9,846 -8,956 -8,918 -8,930 -6,602 -15,925 -34.82%
Tax 796 5 858 698 931 4 843 -3.74%
NP -8,375 -9,851 -8,956 -8,918 -8,930 -6,606 -15,925 -34.82%
Tax Rate - - - - - - - -
Total Cost 10,237 10,294 9,467 9,656 10,298 9,530 16,311 -26.67%
Ratio Analysis
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
NP Margin -449.79 -2,223.70 -1,752.64 -1,208.40 -652.78 -225.92 -4,125.65 -77.14%
Per Share
30/09/21 30/06/21 31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 CAGR
EPS -1.40 -1.65 -1.58 -1.93 -2.03 -1.64 -3.98 -50.13%
EPS Diluted -1.40 -1.65 -1.58 -1.93 -2.03 -1.64 -3.98 -50.13%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.